ID   TRIB3_HUMAN             Reviewed;         358 AA.
AC   Q96RU7; Q53GU4; Q53ZW7; Q6I9Y9; Q8TAI6; Q9H5M8; Q9NUD2;
DT   01-FEB-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-2003, sequence version 2.
DT   12-APR-2017, entry version 154.
DE   RecName: Full=Tribbles homolog 3;
DE            Short=TRB-3;
DE   AltName: Full=Neuronal cell death-inducible putative kinase;
DE   AltName: Full=SINK;
DE   AltName: Full=p65-interacting inhibitor of NF-kappa-B;
GN   Name=TRIB3; Synonyms=C20orf97, NIPK, SKIP3, TRB3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, INDUCTION, AND
RP   INTERACTION WITH ATF4.
RX   PubMed=12743605; DOI=10.1038/sj.onc.1206367;
RA   Bowers A.J., Scully S., Boylan J.F.;
RT   "SKIP3, a novel Drosophila tribbles ortholog, is overexpressed in
RT   human tumors and is regulated by hypoxia.";
RL   Oncogene 22:2823-2835(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, INDUCTION,
RP   AND INTERACTION WITH RELA.
RX   PubMed=12736262; DOI=10.1074/jbc.M209814200;
RA   Wu M., Xu L.G., Zhai Z., Shu H.B.;
RT   "SINK is a p65-interacting negative regulator of NF-kappaB-dependent
RT   transcription.";
RL   J. Biol. Chem. 278:27072-27079(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   INTERACTION WITH MAP2K1 AND MAP2K7.
RX   PubMed=15299019; DOI=10.1074/jbc.M407732200;
RA   Kiss-Toth E., Bagstaff S.M., Sung H.Y., Jozsa V., Dempsey C.,
RA   Caunt J.C., Oxley K.M., Wyllie D.H., Polgar T., Harte M.,
RA   O'Neill L.A.J., Qwarnstrom E.E., Dower S.K.;
RT   "Human tribbles, a protein family controlling mitogen-activated
RT   protein kinase cascades.";
RL   J. Biol. Chem. 279:42703-42708(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=15781252; DOI=10.1016/j.bbrc.2005.02.149;
RA   Ord D., Ord T.;
RT   "Characterization of human NIPK (TRB3, SKIP3) gene activation in
RT   stressful conditions.";
RL   Biochem. Biophys. Res. Commun. 330:210-218(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Shan Y.X., Yu L.;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M.,
RA   Beasley O.P., Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J.,
RA   Buck D., Burrill W.D., Butler A.P., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M., Clark G., Clark L.N., Clark S.Y., Clee C.M.,
RA   Clegg S., Cobley V.E., Collier R.E., Connor R.E., Corby N.R.,
RA   Coulson A., Coville G.J., Deadman R., Dhami P.D., Dunn M.,
RA   Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H.,
RA   Rice C.M., Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M.L., Soderlund C., Steward C.A., Sulston J.E.,
RA   Swann R.M., Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A.,
RA   Tracey A., Tromans A.C., Vaudin M., Wall M., Wallis J.M.,
RA   Whitehead S.L., Whittaker P., Willey D.L., Williams L., Williams S.A.,
RA   Wilming L., Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S.,
RA   Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ARG-84.
RC   TISSUE=Cervix, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   FUNCTION, INDUCTION, AND INTERACTION WITH DDIT3.
RX   PubMed=15775988; DOI=10.1038/sj.emboj.7600596;
RA   Ohoka N., Yoshii S., Hattori T., Onozaki K., Hayashi H.;
RT   "TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP
RT   pathway and is involved in cell death.";
RL   EMBO J. 24:1243-1255(2005).
RN   [12]
RP   INDUCTION.
RX   PubMed=16129579; DOI=10.1016/j.cellsig.2005.08.002;
RA   Schwarzer R., Dames S., Tondera D., Klippel A., Kaufmann J.;
RT   "TRB3 is a PI 3-kinase dependent indicator for nutrient starvation.";
RL   Cell. Signal. 18:899-909(2006).
RN   [13]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.M703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [14]
RP   FUNCTION, INTERACTION WITH APOBEC3A AND APOBEC3C, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22977230; DOI=10.1074/jbc.M112.372722;
RA   Aynaud M.M., Suspene R., Vidalain P.O., Mussil B., Guetard D.,
RA   Tangy F., Wain-Hobson S., Vartanian J.P.;
RT   "Human Tribbles 3 protects nuclear DNA from cytidine deamination by
RT   APOBEC3A.";
RL   J. Biol. Chem. 287:39182-39192(2012).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-60; ARG-84; HIS-153; HIS-274 AND
RP   LYS-347.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Disrupts insulin signaling by binding directly to Akt
CC       kinases and blocking their activation. May bind directly to and
CC       mask the 'Thr-308' phosphorylation site in AKT1. Binds to ATF4 and
CC       inhibits its transcriptional activation activity. Interacts with
CC       the NF-kappa-B transactivator p65 RELA and inhibits its
CC       phosphorylation and thus its transcriptional activation activity.
CC       Interacts with MAPK kinases and regulates activation of MAP
CC       kinases. May play a role in programmed neuronal cell death but
CC       does not appear to affect non-neuronal cells. Does not display
CC       kinase activity. Inhibits the transcriptional activity of
CC       DDIT3/CHOP and is involved in DDIT3/CHOP-dependent cell death
CC       during ER stress. Can inhibit APOBEC3A editing of nuclear DNA.
CC       {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:15299019,
CC       ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:15781252,
CC       ECO:0000269|PubMed:22977230}.
CC   -!- SUBUNIT: Interacts with AKT1, AKT2, ATF4, MAP2K1 and MAP2K7.
CC       Interacts with DDIT3/CHOP and inhibits its interaction with
CC       EP300/P300. Interacts (via N-terminus) with APOBEC3A. Interacts
CC       with APOBEC3C. {ECO:0000269|PubMed:12736262,
CC       ECO:0000269|PubMed:12743605, ECO:0000269|PubMed:15299019,
CC       ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:17872950,
CC       ECO:0000269|PubMed:22977230}.
CC   -!- INTERACTION:
CC       P18848:ATF4; NbExp=8; IntAct=EBI-492476, EBI-492498;
CC       Q96AQ3:ATF4; NbExp=4; IntAct=EBI-492476, EBI-740263;
CC       Q99750:MDFI; NbExp=3; IntAct=EBI-492476, EBI-724076;
CC       O14744:PRMT5; NbExp=2; IntAct=EBI-492476, EBI-351098;
CC       Q96KN7:RPGRIP1; NbExp=3; IntAct=EBI-492476, EBI-1050213;
CC       Q96KN7-4:RPGRIP1; NbExp=3; IntAct=EBI-492476, EBI-11525164;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22977230}.
CC   -!- TISSUE SPECIFICITY: Highest expression in liver, pancreas,
CC       peripheral blood leukocytes and bone marrow. Also highly expressed
CC       in a number of primary lung, colon and breast tumors. Expressed in
CC       spleen, thymus, and prostate and is undetectable in other examined
CC       tissues, including testis, ovary, small intestine, colon,
CC       leukocyte, heart, brain, placenta, lung, skeletal muscle, and
CC       kidney. {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:12743605,
CC       ECO:0000269|PubMed:15299019}.
CC   -!- INDUCTION: By hypoxia, TNF, and by nutrient starvation. Expression
CC       is PI 3-kinase and/or NF-kappa-B-dependent. Induced by ER stress
CC       via ATF4-DDIT3/CHOP pathway and can downregulate its own induction
CC       by repression of ATF4-DDIT3/CHOP functions.
CC       {ECO:0000269|PubMed:12736262, ECO:0000269|PubMed:12743605,
CC       ECO:0000269|PubMed:15775988, ECO:0000269|PubMed:16129579}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. Tribbles subfamily. {ECO:0000305}.
CC   -!- CAUTION: The role of this protein in Akt activation has been
CC       demonstrated by Du et al (PubMed:12791994) for the mouse ortholog
CC       but Iynedjian (PubMed:15469416) has not been able to reproduce the
CC       result in rat hepatocytes. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF250311; AAK58175.1; -; mRNA.
DR   EMBL; AJ697936; CAG27047.1; -; mRNA.
DR   EMBL; AY247738; AAP04407.1; -; mRNA.
DR   EMBL; AK026945; BAB15597.1; -; mRNA.
DR   EMBL; CR457366; CAG33647.1; -; mRNA.
DR   EMBL; AK222837; BAD96557.1; -; mRNA.
DR   EMBL; AL034548; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC019363; AAH19363.1; -; mRNA.
DR   EMBL; BC027484; AAH27484.1; -; mRNA.
DR   CCDS; CCDS12997.1; -.
DR   RefSeq; NP_001288117.1; NM_001301188.1.
DR   RefSeq; NP_001288119.1; NM_001301190.1.
DR   RefSeq; NP_001288122.1; NM_001301193.1.
DR   RefSeq; NP_001288125.1; NM_001301196.1.
DR   RefSeq; NP_001288130.1; NM_001301201.1.
DR   RefSeq; NP_066981.2; NM_021158.4.
DR   UniGene; Hs.516826; -.
DR   ProteinModelPortal; Q96RU7; -.
DR   SMR; Q96RU7; -.
DR   BioGrid; 121756; 36.
DR   IntAct; Q96RU7; 17.
DR   MINT; MINT-1384866; -.
DR   STRING; 9606.ENSP00000217233; -.
DR   iPTMnet; Q96RU7; -.
DR   PhosphoSitePlus; Q96RU7; -.
DR   BioMuta; TRIB3; -.
DR   DMDM; 28201830; -.
DR   EPD; Q96RU7; -.
DR   MaxQB; Q96RU7; -.
DR   PaxDb; Q96RU7; -.
DR   PeptideAtlas; Q96RU7; -.
DR   PRIDE; Q96RU7; -.
DR   DNASU; 57761; -.
DR   Ensembl; ENST00000217233; ENSP00000217233; ENSG00000101255.
DR   GeneID; 57761; -.
DR   KEGG; hsa:57761; -.
DR   UCSC; uc002wdm.4; human.
DR   CTD; 57761; -.
DR   DisGeNET; 57761; -.
DR   GeneCards; TRIB3; -.
DR   HGNC; HGNC:16228; TRIB3.
DR   MIM; 607898; gene.
DR   neXtProt; NX_Q96RU7; -.
DR   OpenTargets; ENSG00000101255; -.
DR   PharmGKB; PA25804; -.
DR   eggNOG; KOG0583; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00870000136390; -.
DR   HOGENOM; HOG000231872; -.
DR   HOVERGEN; HBG067729; -.
DR   InParanoid; Q96RU7; -.
DR   KO; K19518; -.
DR   PhylomeDB; Q96RU7; -.
DR   TreeFam; TF329785; -.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-HSA-165158; Activation of AKT2.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-199418; Negative regulation of the PI3K/AKT network.
DR   Reactome; R-HSA-389357; CD28 dependent PI3K/Akt signaling.
DR   Reactome; R-HSA-5218920; VEGFR2 mediated vascular permeability.
DR   SignaLink; Q96RU7; -.
DR   SIGNOR; Q96RU7; -.
DR   ChiTaRS; TRIB3; human.
DR   GeneWiki; TRIB3; -.
DR   GenomeRNAi; 57761; -.
DR   PRO; PR:Q96RU7; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   Bgee; ENSG00000101255; -.
DR   CleanEx; HS_TRIB3; -.
DR   ExpressionAtlas; Q96RU7; baseline and differential.
DR   Genevisible; Q96RU7; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0031434; F:mitogen-activated protein kinase kinase binding; IBA:GO_Central.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004860; F:protein kinase inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; ISS:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISS:BHF-UCL.
DR   GO; GO:0055106; F:ubiquitin-protein transferase regulator activity; ISS:BHF-UCL.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; ISS:BHF-UCL.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0045599; P:negative regulation of fat cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0045717; P:negative regulation of fatty acid biosynthetic process; ISS:BHF-UCL.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription from RNA polymerase II promoter; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0032092; P:positive regulation of protein binding; ISS:BHF-UCL.
DR   GO; GO:0051443; P:positive regulation of ubiquitin-protein transferase activity; ISS:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; IEA:InterPro.
DR   GO; GO:0010827; P:regulation of glucose transport; ISS:BHF-UCL.
DR   GO; GO:0043405; P:regulation of MAP kinase activity; IDA:UniProtKB.
DR   GO; GO:0034976; P:response to endoplasmic reticulum stress; IDA:UniProtKB.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR024104; Tribbles/Ser_Thr_kinase_40.
DR   InterPro; IPR024106; Tribbles_TRB3.
DR   PANTHER; PTHR22961; PTHR22961; 1.
DR   PANTHER; PTHR22961:SF21; PTHR22961:SF21; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; Complete proteome; Nucleus; Phosphoprotein; Polymorphism;
KW   Protein kinase inhibitor; Reference proteome; Stress response;
KW   Transcription; Transcription regulation.
FT   CHAIN         1    358       Tribbles homolog 3.
FT                                /FTId=PRO_0000131866.
FT   DOMAIN       68    316       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION        1    127       Interaction with DDIT3/CHOP.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VARIANT      60     60       T -> I (in a glioblastoma multiforme
FT                                sample; somatic mutation;
FT                                dbSNP:rs757496714).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042372.
FT   VARIANT      84     84       Q -> R (in dbSNP:rs2295490).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_023965.
FT   VARIANT     153    153       R -> H (in dbSNP:rs35051116).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042373.
FT   VARIANT     274    274       R -> H (in dbSNP:rs56291463).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042374.
FT   VARIANT     347    347       E -> K (in dbSNP:rs56342286).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042375.
FT   CONFLICT     24     24       N -> D (in Ref. 7; CAG33647).
FT                                {ECO:0000305}.
FT   CONFLICT    105    105       L -> P (in Ref. 6; BAB15597 and 8;
FT                                BAD96557). {ECO:0000305}.
FT   CONFLICT    114    114       L -> V (in Ref. 3; AAK58175).
FT                                {ECO:0000305}.
FT   CONFLICT    194    195       ER -> DREK (in Ref. 3; AAK58175).
FT                                {ECO:0000305}.
SQ   SEQUENCE   358 AA;  39578 MW;  CE15FD89A81E8D63 CRC64;
     MRATPLAAPA GSLSRKKRLE LDDNLDTERP VQKRARSGPQ PRLPPCLLPL SPPTAPDRAT
     AVATASRLGP YVLLEPEEGG RAYQALHCPT GTEYTCKVYP VQEALAVLEP YARLPPHKHV
     ARPTEVLAGT QLLYAFFTRT HGDMHSLVRS RHRIPEPEAA VLFRQMATAL AHCHQHGLVL
     RDLKLCRFVF ADRERKKLVL ENLEDSCVLT GPDDSLWDKH ACPAYVGPEI LSSRASYSGK
     AADVWSLGVA LFTMLAGHYP FQDSEPVLLF GKIRRGAYAL PAGLSAPARC LVRCLLRREP
     AERLTATGIL LHPWLRQDPM PLAPTRSHLW EAAQVVPDGL GLDEAREEEG DREVVLYG
//
